ResMed Announces Participation in KeyBanc’s Capital Markets' Life Sciences & MedTech Investor Forum
16 Março 2021 - 10:00AM
Business Wire
ResMed (NYSE: RMD, ASX: RMD) today announced Rob Douglas,
president and chief operating officer and Brett Sandercock, chief
financial officer, will participate in a virtual fireside chat at
the KeyBanc Capital Markets' Life Sciences & MedTech Investor
Forum on Tuesday, March 23, 2021, beginning at approximately 4:15
p.m. (Eastern Daylight Time) via video webcast.
More information about this event, including access to the live
webcast, may be accessed by visiting http://investor.resmed.com.
The webcast replay will be available approximately one hour after
the live webcast ends and will be accessible through June 21,
2021.
About ResMed
At ResMed (NYSE: RMD, ASX: RMD) we pioneer innovative solutions
that treat and keep people out of the hospital, empowering them to
live healthier, higher-quality lives. Our digital health
technologies and cloud-connected medical devices transform care for
people with sleep apnea, COPD, and other chronic diseases. Our
comprehensive out-of-hospital software platforms support the
professionals and caregivers who help people stay healthy in the
home or care setting of their choice. By enabling better care, we
improve quality of life, reduce the impact of chronic disease, and
lower costs for consumers and healthcare systems in more than 140
countries. To learn more, visit ResMed.com and follow @ResMed.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20210316005034/en/
For investors Amy Wakeham +1 858.836.5000
investorrelations@resmed.com
For media Jayme Rubenstein +1 858.836.6798
news@resmed.com
Resmed (ASX:RMD)
Gráfico Histórico do Ativo
De Nov 2024 até Dez 2024
Resmed (ASX:RMD)
Gráfico Histórico do Ativo
De Dez 2023 até Dez 2024
Notícias em tempo-real sobre Resmed Inc da Australian Stock Exchange bolsa de valores: 0 artigos recentes
Mais Notícias de Resmed Cdi 10:1